Episome Biotechnologies

Episome offers innovative and sustainable solutions which solve the paper industry's massive waste problem. Episome's newly developed patented technology, Epicellulyse XT, enables use of paper mill sludge (waste) in biogas/renewable energy and organic fertilizer production. Previously paper mill sludge was not suitable for biogas production due to its cellulose content.

Episome has already developed Epicellulyse XT (Xerophilic Technology)'s lab scale prototype and also pilot plant on site. First contract has been signed to establish commercial facility in Netherlands. Episome has raised 1.7 Million Euros in 2017.

Potential customers: Pulp and paper industries, biogas industries, green energy industries
Total addressable market is apprx. 0.5 Billion Euros for Europe, 1.4 Billion Euros for the globe. Episome aims to reach 5% in 5 years and 20% in 10 years. Market is growing 5-7% yearly with increasing life prosperity enhancement and growing online retailing.

Paper industry has a massive waste problem, pulp and paper industry is the 6th.largest polluter of the earth. Every year globally, 3 Billion Euros is spent for disposal of paper industry waste and related fines&fees. For a medium size plant this cost is nearly 7 Million Euros. Paper Industry needs an environment friendly, sustainable, profitable waste disposal method.

Episome designs,develops and produces special biogas plants, based on its novel enzymatic pretreatment technology that solves this huge waste problem. Annually, Epicellulyse XT reduces 12M tons green house gases and saves 40.000*olympic-size swimming pools volume as not being landfill. Episome's new technology is market ready and contributes to paper industry for a strong PR. Today it's right time to invest for this circular economy solution.

The main disposal routes for paper sludge are incineration in combined heat and power plants at the paper mill, producing paper sludge ash/GHGs or disposal to landfill. However,these disposing methods of paper sludge are temporary solutions due to their unsustainable,costly or environmentally unfriendly approaches. Epicellulyse XT has a reasonable CAPEX, verylittle
OPEX and the most important, we earn money,all others burn money! ROI is always less than 5 years and environment friendly.

Annually, Epicellulyse XT reduces 12M tons green house gases and saves 40.000*olympic-size swimming pools volume as not being landfill.Episome's new technology is market ready and contributes to paper industry for a
strong PR.Today it's right time to invest for this circular economy solution.

Episome will generate revenue by selling design&consulting services (0.05 Euros/mTon), advanced biogas plants (1.5 Euros/mTon) and our novel enzyme, Cellurise (24 Euros/mTon). Sale strategy is direct sale to paper mills, sales via strategic partners. Medium size one paper mill means 2.5 Million Euros revenue/year. Gross margin is nearly 60%.

Sale strategy is direct sale to paper mills, sales via strategic partners. Medium size one paper mill means 2.5 Million Euros revenue/year. Gross margin is nearly 60%.

Establishment of a demo facility in Europe

Energy Globe(National Winner), Global Cleantech Innovation Program 2017 - Los Angeles (1st.Rank-National Winner), 2016 TECHIN2B TECHARENA - Istanbul (1st. Rank), Falling Walls 2017 - Berlin, 2018, Invest Istanbul-London (Finalist)

Granted Patents: EPO (European Countries), Japan, USA, Indonesia, and South Korea